These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35462491)

  • 1. [A case of hemochromatosis associated with transferrin receptor 2 gene mutations].
    Liu XH; Zheng SJ; Gao LY; Zhang L
    Zhonghua Gan Zang Bing Za Zhi; 2022 Mar; 30(3):325-327. PubMed ID: 35462491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hemochromatosis gene.
    Leber BF
    Clin Invest Med; 2000 Dec; 23(6):382-6. PubMed ID: 11152407
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetic hemochromatosis update.
    Brissot P; Le Lan C; Lorho R; Gaboriau F; Lescoat G; Loréal O
    Acta Gastroenterol Belg; 2005; 68(1):33-7. PubMed ID: 15832585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemochromatosis and severe iron overload associated with compound heterozygosity for TFR2 R455Q and two novel mutations TFR2 R396X and G792R.
    Lee PL; Barton JC
    Acta Haematol; 2006; 115(1-2):102-5. PubMed ID: 16424658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transferrin receptor-2 gene and non-C282Y homozygous patients with hemochromatosis.
    Aguilar-Martinez P; Esculié-Coste C; Bismuth M; Giansily-Blaizot M; Larrey D; Schved JF
    Blood Cells Mol Dis; 2001; 27(1):290-3. PubMed ID: 11358390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hereditary hemochromatosis--a new look at an old disease.
    Pietrangelo A
    N Engl J Med; 2004 Jun; 350(23):2383-97. PubMed ID: 15175440
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of a reverse hybridization strip assay for the study of hemochromatosis-associated gene mutations in Lebanon.
    Daher RT; Khalik RN; Hoteit RM; Sarieddine DS; Charafeddine KM; Cortas NK; Mahfouz RA
    Genet Test Mol Biomarkers; 2011 Dec; 15(12):909-11. PubMed ID: 21689013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel observations in hereditary hemochromatosis: potential implications for clinical strategies.
    Swinkels DW; Fleming RE
    Haematologica; 2011 Apr; 96(4):485-8. PubMed ID: 21454877
    [No Abstract]   [Full Text] [Related]  

  • 9. Iron overload in acute myeloid leukemia patients is not related to HFE and TFR2 gene mutations.
    Veneri D; Franchini M; Zanetti F; Krampera M; de Matteis G; Pizzolo G
    Haematologica; 2003 Sep; 88(9):1069-70. PubMed ID: 12969816
    [No Abstract]   [Full Text] [Related]  

  • 10. Transferrin receptor mutation analysis in hereditary hemochromatosis patients.
    Tsuchihashi Z; Hansen SL; Quintana L; Kronmal GS; Mapa FA; Feder JN; Wolff RK
    Blood Cells Mol Dis; 1998 Sep; 24(3):317-21. PubMed ID: 10087990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemochromatosis: genetics and pathophysiology.
    Beutler E
    Annu Rev Med; 2006; 57():331-47. PubMed ID: 16409153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical and genetic aspects of hereditary hemochromatosis].
    Bosserhoff AK; Hellerbrand C; Buettner R
    Pathologe; 2001 May; 22(3):191-6. PubMed ID: 11402849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary hemochromatosis--sometimes having a real complex can be a good thing.
    Rouault TA
    Hepatology; 1998 Sep; 28(3):890-1. PubMed ID: 9731588
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecular insights into the pathogenesis of hereditary haemochromatosis.
    Pietrangelo A
    Gut; 2006 Apr; 55(4):564-8. PubMed ID: 16531535
    [No Abstract]   [Full Text] [Related]  

  • 15. Mutations in HFE and TFR2 genes in a Spanish patient with hemochromatosis.
    Rueda Adel C; Grande NC; Fernández EA; Enríquez de Salamanca R; Sala LA; Jiménez MJ
    Rev Esp Enferm Dig; 2011 Jul; 103(7):379-82. PubMed ID: 21770687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-HFE hemochromatosis.
    Pietrangelo A
    Semin Liver Dis; 2005 Nov; 25(4):450-60. PubMed ID: 16315138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathophysiology and genetics of classic HFE (type 1) hemochromatosis].
    Loréal O; Ropert M; Mosser A; Déhais V; Deugnier Y; David V; Brissot P; Jouanolle AM
    Presse Med; 2007 Sep; 36(9 Pt 2):1271-7. PubMed ID: 17521857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of the hemochromatosis gene product HFE with transferrin receptor modulates cellular iron metabolism.
    Eisenstein RS
    Nutr Rev; 1998 Dec; 56(12):356-8. PubMed ID: 9884584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of new mutations of the HFE, hepcidin, and transferrin receptor 2 genes by denaturing HPLC analysis of individuals with biochemical indications of iron overload.
    Biasiotto G; Belloli S; Ruggeri G; Zanella I; Gerardi G; Corrado M; Gobbi E; Albertini A; Arosio P
    Clin Chem; 2003 Dec; 49(12):1981-8. PubMed ID: 14633868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transferrin receptor 2 (TfR2) and HFE mutational analysis in non-C282Y iron overload: identification of a novel TfR2 mutation.
    Mattman A; Huntsman D; Lockitch G; Langlois S; Buskard N; Ralston D; Butterfield Y; Rodrigues P; Jones S; Porto G; Marra M; De Sousa M; Vatcher G
    Blood; 2002 Aug; 100(3):1075-7. PubMed ID: 12130528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.